NovaBay Pharmaceuticals Inc (NBY) — Cash Flow Reinvestment Rate
NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow Reinvestment Rate of 0.26x as of September 2017, reinvesting $73.00K (capex $73.00K ) from operating cash flow of $281.00K. See NovaBay Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NovaBay Pharmaceuticals Inc Cash Flow Reinvestment Rate (2006–2010)
Historical reinvestment intensity for NovaBay Pharmaceuticals Inc across 2 annual periods. For the full cash flow conversion analysis, see NBY cash flow metrics.
Annual Cash Flow Reinvestment Rate for NovaBay Pharmaceuticals Inc (2006–2010)
Year-by-year capital reinvestment analysis for NovaBay Pharmaceuticals Inc. See NovaBay Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.10x | $203.00K | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $362.00K | $4.74 Million | $362.00K | — |